Abiopharma

🔍 Sfadia Adi (Executive)

Company: GILAT SATELLITE NETWORKS LTD (GILT)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Sold 3,978 shares of Ordinary Shares at $16.8498 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 37,500 shares of Ordinary Shares at $16.8498 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,500.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 7,500 shares of Ordinary Shares at $16.8498 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 6,010 shares of Stock Option (Right to Buy) at $5.68 per share (Derivative)
  Date: 2026-03-18 | Code: M | Expires: 2029-02-13 | Exercise: 2024-02-13 | equity_swap_involved: 0 | shares_owned_after: 25,000.00 | transaction_form_type: 4 | Footnotes: F5

Footnotes:

• F1: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025
• F2: The reporting person exercised stock options on a net basis. Shares were withheld to cover the exercise price, resulting in the issuance of 3,978 shares, all of which were sold on the same day.
• F3: The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request.
• F4: Represents shares received upon the vesting of Performance Stock Units granted on 02/13/2025.
• F5: The reporting person exercised 6,010 stock options on a net basis. Shares were withheld to cover the aggregate exercise price, resulting in the issuance of 3,978 shares. All shares received upon exercise were sold on the same day, as reported in Table I.